These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 31826995
1. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization. Komala Sari T, Gianopulos KA, Nicola AV. J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995 [Abstract] [Full Text] [Related]
2. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. J Virol; 2008 Jul 14; 82(14):6935-41. PubMed ID: 18480440 [Abstract] [Full Text] [Related]
3. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus. Krawczyk A, Krauss J, Eis-Hübinger AM, Däumer MP, Schwarzenbacher R, Dittmer U, Schneweis KE, Jäger D, Roggendorf M, Arndt MA. J Virol; 2011 Feb 14; 85(4):1793-803. PubMed ID: 21123390 [Abstract] [Full Text] [Related]
4. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific. Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ. J Virol; 2015 Sep 14; 89(18):9213-31. PubMed ID: 26109729 [Abstract] [Full Text] [Related]
5. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects. Criscuolo E, Castelli M, Diotti RA, Amato V, Burioni R, Clementi M, Ambrosi A, Mancini N, Clementi N. J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30867302 [Abstract] [Full Text] [Related]
6. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus. Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y. Antiviral Res; 2017 Nov 01; 147():131-141. PubMed ID: 29061442 [Abstract] [Full Text] [Related]
7. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine. Awasthi S, Lubinski JM, Friedman HM. Vaccine; 2009 Nov 16; 27(49):6845-53. PubMed ID: 19761834 [Abstract] [Full Text] [Related]
8. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. Cairns TM, Fontana J, Huang ZY, Whitbeck JC, Atanasiu D, Rao S, Shelly SS, Lou H, Ponce de Leon M, Steven AC, Eisenberg RJ, Cohen GH. J Virol; 2014 Mar 16; 88(5):2677-89. PubMed ID: 24352457 [Abstract] [Full Text] [Related]
9. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans. Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH. J Virol; 2014 Nov 16; 88(21):12612-22. PubMed ID: 25142599 [Abstract] [Full Text] [Related]
10. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane. Fontana J, Atanasiu D, Saw WT, Gallagher JR, Cox RG, Whitbeck JC, Brown LM, Eisenberg RJ, Cohen GH. mBio; 2017 Aug 22; 8(4):. PubMed ID: 28830949 [Abstract] [Full Text] [Related]
11. Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry. Komala Sari T, Gianopulos KA, Weed DJ, Schneider SM, Pritchard SM, Nicola AV. mSphere; 2020 Feb 05; 5(1):. PubMed ID: 32024702 [Abstract] [Full Text] [Related]
12. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH. J Virol; 1998 May 05; 72(5):3595-601. PubMed ID: 9557640 [Abstract] [Full Text] [Related]
13. Conformational Changes in Herpes Simplex Virus Glycoprotein C. Gianopulos KA, Komala Sari T, Weed DJ, Pritchard SM, Nicola AV. J Virol; 2022 Aug 24; 96(16):e0016322. PubMed ID: 35913218 [Abstract] [Full Text] [Related]
14. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay. Kinoshita H, Yamada S, Ogawa T, Nguyen PHA, Harada S, Kawahara M, Ishijima K, Maeda K, Ebihara H, Fukushi S. mBio; 2024 Jul 17; 15(7):e0109224. PubMed ID: 38847539 [Abstract] [Full Text] [Related]
15. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1. Friedman HM, Wang L, Pangburn MK, Lambris JD, Lubinski J. J Immunol; 2000 Oct 15; 165(8):4528-36. PubMed ID: 11035093 [Abstract] [Full Text] [Related]
16. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice. Gmyrek GB, Filiberti A, Montgomery M, Chitrakar A, Royer DJ, Carr DJJ. J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999018 [Abstract] [Full Text] [Related]
17. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. Friedman HM, Wang L, Fishman NO, Lambris JD, Eisenberg RJ, Cohen GH, Lubinski J. J Virol; 1996 Jul 23; 70(7):4253-60. PubMed ID: 8676446 [Abstract] [Full Text] [Related]
18. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors. Atanasiu D, Cairns TM, Whitbeck JC, Saw WT, Rao S, Eisenberg RJ, Cohen GH. mBio; 2013 Feb 26; 4(2):. PubMed ID: 23443004 [Abstract] [Full Text] [Related]
19. Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes. Hilterbrand AT, Daly RE, Heldwein EE. mBio; 2021 Mar 02; 12(2):. PubMed ID: 33653890 [Abstract] [Full Text] [Related]